AHLA Health Law Watch (Non-Members)
Now more than ever, you can look to this annual reference to inform your strategy, understand emerging issues, and anticipate problems. Against the backdrop of a dramatically changed landscape, the 2021 edition of Health Law Watch provides extensive analysis and insight on numerous legal and operational challenges facing the health care industry. You'll turn to it again and again as a quick reference on these critical topics, and as your strategic thinking—and the law—evolves.
Select a format
Select subscription type
Terms & conditions
Subscribers receive the product(s) listed on the Order Form and any Updates made available during the annual subscription period. Shipping and handling fees are not included in the annual price.
Subscribers are advised of the number of Updates that were made to the particular publication the prior year. The number of Updates may vary due to developments in the law and other publishing issues, but subscribers may use this as a rough estimate of future shipments. Subscribers may call Customer Support at 800-833-9844 for additional information.
Subscribers may cancel this subscription by: calling Customer Support at 800-833-9844; emailing email@example.com; or returning the invoice marked "CANCEL".
If subscribers cancel within 30 days after the product is ordered or received and return the product at their expense, then they will receive a full credit of the price for the annual subscription.
If subscribers cancel between 31 and 60 days after the invoice date and return the product at their expense, then they will receive a 5/6th credit of the price for the annual subscription. No credit will be given for cancellations more than 60 days after the invoice date. To receive any credit, subscriber must return all product(s) shipped during the year at their expense within the applicable cancellation period listed above.
A 2021 Edition for A Changed Industry
Three years ago, the first edition of Health Law Watch was intended to serve as a quick reference to the top ten issues in health law. Since then, this title has evolved to serve not only that purpose, but also to stimulate deep thinking on the most difficult issues facing the health care profession. With their close analysis, the authors of this 2021 Edition have raised the bar, preparing readers to understand the tensions that health care industry stakeholders will face in both the short and long terms.
As even a casual observer of health law knows, the COVID-19 public health emergency highlighted obstacles and accelerated change in health care delivery and regulation, as policymakers, providers, and patients struggled to adapt. What experienced health law professionals understood is that these changes were not the first attempts to address longstanding challenges facing our industry. In this 2021 Edition, health lawyers explain the bases for those challenges, take stock of where we are in the wake of the pandemic, and foreshadow what may come next.
AUTHORS: Ranee Adipat, Alan J. Brudner, Colin Callahan, Samuel (Sammy) M. Chang, Danielle Pelfrey Duryea, Jeff Dutson, Deborah Farringer, Andrea Frey, Jeremy A. Gunn, Clint Hermes, Nicole Huberfeld, Heath Roosevelt Ingram, Travis Jackson, Cathryn (Cat) Johns, Karen Mandelbaum, Torrey McClary, Elaine Naughton, LaRae' Neal, Delphine O'Rourke, Jorge L. Rivera-Agosto, Christopher C. Sabis, Angelique Salib, Elizabeth (Beth) Scarola, Alaap Shah, Jeremy Sherer, Thomas J. Sullivan, Ruqaiijah Yearby
For full author bios, please click here.
The ISBN for the 2020 Edition was 9781522196327.
eBooks, CDs, downloadable content, and software purchases are noncancelable, nonrefundable and nonreturnable. Click here for more information about LexisNexis eBooks. The eBook versions of this title may feature links to Lexis+® service for further legal research options. A valid subscription to Lexis+ is required to access this content.
Published August, 2021.
Table of contents
Chapter 1 Disparities in Health Care: The Pandemic's Lessons for Health Lawyers
Chapter 2 Corporate and Transactional Considerations for Health Care Entities in
Chapter 3 Human Subjects Research in Clinical Trials During the Pandemic
Chapter 4 Proliferation of Health Care Data: Navigating Interoperability and Data
Sharing Opportunities and Challenges
Chapter 5 Fraud Enforcement in the Digital Arena— Electronic Health Records
Chapter 6 Federal Preemption of State Health Care Regulation
Chapter 7 Post-Pandemic Telehealth Arrangements: Established Authority, Changing
Requirements, and Industry Volatility
Chapter 8 State Drug Transparency Laws: Considerations for Pharmaceutical
Chapter 9 Mental Health Parity and Trends in Post-Pan- demic Behavioral Health Care
Chapter 10 Legal and Regulatory Waivers and Immunities in the Context of COVID-19